
Kevin M. Picardat
Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2813, 2825, 1104, 2899, 2822, 1763, 1732 |
| Total Applications | 2640 |
| Issued Applications | 2463 |
| Pending Applications | 47 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7026616
[patent_doc_number] => 20050020531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Systemic carnitine deficiency gene and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/940500
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7099
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10940500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/940500 | Systemic carnitine deficiency gene and uses thereof | Sep 12, 2004 | Issued |
Array
(
[id] => 4463830
[patent_doc_number] => 07935501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-03
[patent_title] => 'Recombinant production of antimicrobial peptides'
[patent_app_type] => utility
[patent_app_number] => 10/572016
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19511
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/935/07935501.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572016
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572016 | Recombinant production of antimicrobial peptides | Sep 12, 2004 | Issued |
Array
(
[id] => 52334
[patent_doc_number] => 07771755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins'
[patent_app_type] => utility
[patent_app_number] => 10/937364
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8492
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/771/07771755.pdf
[firstpage_image] =>[orig_patent_app_number] => 10937364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/937364 | Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins | Sep 9, 2004 | Issued |
Array
(
[id] => 6292414
[patent_doc_number] => 20100159492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'Method for the Diagnosis of Diseases by Determining Apolipoprotein C-1'
[patent_app_type] => utility
[patent_app_number] => 10/572522
[patent_app_country] => US
[patent_app_date] => 2004-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5785
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20100159492.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572522 | Method for the Diagnosis of Diseases by Determining Apolipoprotein C-1 | Sep 6, 2004 | Abandoned |
Array
(
[id] => 5709996
[patent_doc_number] => 20060051341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Methods for treating a buttock deformity'
[patent_app_type] => utility
[patent_app_number] => 10/934810
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12582
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051341.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934810
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934810 | Methods for treating a buttock deformity | Sep 2, 2004 | Issued |
Array
(
[id] => 7034165
[patent_doc_number] => 20050032675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix'
[patent_app_type] => utility
[patent_app_number] => 10/928407
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4818
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032675.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928407
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928407 | Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix | Aug 29, 2004 | Abandoned |
Array
(
[id] => 7171935
[patent_doc_number] => 20050203004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Pharmacologically active polypeptide glycoconjugates'
[patent_app_type] => utility
[patent_app_number] => 10/930729
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10173
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10930729
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/930729 | Pharmacologically active polypeptide glycoconjugates | Aug 29, 2004 | Issued |
Array
(
[id] => 7088542
[patent_doc_number] => 20050008654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Chimeric proteins'
[patent_app_type] => utility
[patent_app_number] => 10/918366
[patent_app_country] => US
[patent_app_date] => 2004-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11596
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008654.pdf
[firstpage_image] =>[orig_patent_app_number] => 10918366
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/918366 | Chimeric proteins | Aug 15, 2004 | Abandoned |
Array
(
[id] => 914493
[patent_doc_number] => 07326682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-05
[patent_title] => 'Conotoxin peptides'
[patent_app_type] => utility
[patent_app_number] => 10/918096
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9233
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/326/07326682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10918096
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/918096 | Conotoxin peptides | Aug 12, 2004 | Issued |
Array
(
[id] => 285636
[patent_doc_number] => 07550563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain'
[patent_app_type] => utility
[patent_app_number] => 10/567422
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14196
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567422
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567422 | Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain | Aug 4, 2004 | Issued |
Array
(
[id] => 7182925
[patent_doc_number] => 20050191315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Identification of epitopes on staphylococcal enterotoxins'
[patent_app_type] => utility
[patent_app_number] => 10/903478
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19951
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191315.pdf
[firstpage_image] =>[orig_patent_app_number] => 10903478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/903478 | Identification of epitopes on staphylococcal enterotoxins | Aug 1, 2004 | Abandoned |
Array
(
[id] => 7126959
[patent_doc_number] => 20050058703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Gelatin capsules'
[patent_app_type] => utility
[patent_app_number] => 10/901816
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9384
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10901816
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/901816 | Gelatin capsules | Jul 28, 2004 | Abandoned |
| 10/897395 | WD-40 derived peptides and uses thereof | Jul 21, 2004 | Abandoned |
Array
(
[id] => 5131556
[patent_doc_number] => 20070207953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Host Defense Factor X (HDFX)'
[patent_app_type] => utility
[patent_app_number] => 10/564946
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2350
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207953.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564946 | Host Defense Factor X (HDFX) | Jul 15, 2004 | Abandoned |
Array
(
[id] => 7254759
[patent_doc_number] => 20050075277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects'
[patent_app_type] => utility
[patent_app_number] => 10/889539
[patent_app_country] => US
[patent_app_date] => 2004-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9398
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075277.pdf
[firstpage_image] =>[orig_patent_app_number] => 10889539
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/889539 | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects | Jul 11, 2004 | Abandoned |
Array
(
[id] => 7104975
[patent_doc_number] => 20050107289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Anti-microbial peptides and compositions'
[patent_app_type] => utility
[patent_app_number] => 10/886165
[patent_app_country] => US
[patent_app_date] => 2004-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 37204
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10886165
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/886165 | Anti-microbial peptides and compositions | Jul 5, 2004 | Abandoned |
Array
(
[id] => 907721
[patent_doc_number] => 07332598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-19
[patent_title] => 'Non-oligomerizing tandem fluorescent proteins'
[patent_app_type] => utility
[patent_app_number] => 10/885988
[patent_app_country] => US
[patent_app_date] => 2004-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26521
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/332/07332598.pdf
[firstpage_image] =>[orig_patent_app_number] => 10885988
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/885988 | Non-oligomerizing tandem fluorescent proteins | Jul 5, 2004 | Issued |
Array
(
[id] => 5851738
[patent_doc_number] => 20060234929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Rasgap derived peptide for selectively killing cancer cells'
[patent_app_type] => utility
[patent_app_number] => 10/563536
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10665
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563536
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563536 | RasGAP derived peptide for selectively killing cancer cells | Jun 29, 2004 | Issued |
Array
(
[id] => 7025456
[patent_doc_number] => 20050019850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Method for identifying fungicidally active compounds based on guanylate kinases'
[patent_app_type] => utility
[patent_app_number] => 10/881046
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10972
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10881046
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/881046 | Method for identifying fungicidally active compounds based on guanylate kinases | Jun 29, 2004 | Abandoned |
Array
(
[id] => 7110583
[patent_doc_number] => 20050208038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions'
[patent_app_type] => utility
[patent_app_number] => 10/869751
[patent_app_country] => US
[patent_app_date] => 2004-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20607
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10869751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/869751 | Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions | Jun 15, 2004 | Issued |